About Child Health Institute

The Child Health Institute of New Jersey is a comprehensive biomedical research center dedicated to improving child health through the study of mechanisms underlying children's diseases.  The groundbreaking research of the Institute's scientists is integrated with the clinical approaches of pediatric physicians to understand the causes, and improve the therapy and prevention of childhood illness.

The Institute is the cornerstone of the children's academic health campus in New Brunswick and collaborates in its research initiatives with Rutgers Robert Wood Johnson Medical School's Department of Pediatrics and Pediatric Clinical Research Center, The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital, and PSE&G Children's Specialized Hospital.  Together, they form a unique partnership of world-class institutions representing an exciting opportunity for the translation of research findings into improved pediatric care.

 

There are four major areas of research at Child Health Institute:

Inflammatory, immune and infectious diseases of childhood:  Researchers are collaborating with pediatricians at the medical school to investigate autoimmune disorders, asthma and type 1 diabetes.  The team is working to establish two multidisciplinary centers:  the Center for Asthma Research and the Center for Type 1 Diabetes.  Institute investigators also collaborate with pediatric rheumatologists investigating diseases such as pediatric lupus and juvenile idiopathic arthritis.

Neurodevelopment and autism:  The Institute has recruited outstanding scientists who work with colleagues across Robert Wood Johnson Medical School and Rutgers, as well as with clinicians at PSE&G Children’s Specialized Hospital, to study the causes and treatments of autism and other neurodevelopmental disorders.  The high rates of autism in New Jersey lend urgency to this research.

Pediatric cancers and stem cells:  Institute investigators are working with scientists at Rutgers Cancer Institute of New Jersey to understand how pediatric cancers, including leukemia, arise from mutated tissue stem cells.  They are also studying how adult stem cells may be used as novel therapies in regenerative and reparative medicine.

Childhood obesity and metabolism:  In collaboration with pediatricians and scientists at the Rutgers Robert Wood Johnson Medical School and across Rutgers, Institute investigators are studying the neurological, genetic, environmental, and inflammatory causes of obesity and its consequences for the long term.

 

SAVE THE DATE!

The Annual Dr. Kenneth S. and Audrey S. Gould Lecture in Cellular and Molecular Medicine will be held on Thursday, October 29th at noon.

This years' invited speaker is W. Ian Lipkin, MD, a world famous virologist from Columbia University who has used the latest exciting DNA sequencing technologies to discover new disease-causing viruses and to track the evolution and spread of known viruses such as Ebola.

 

 

THE CHILD HEALTH INSTITUTE OF NJ IS 10 YEARS YOUNG. CELEBRATE WITH US!

 

For more information click on the image above.

 

NEW AWARD ANNOUNCEMENT!

 

Dr. Arnold Rabson, Director of Child Health Institute, received the R. Walter Schlesinger M.D. Basic Science Mentoring Award for longstanding guidance and support of young scientists.

 

 

CHI WELCOMES NEW FACULTY!

 

Sally Radovick, MD, Professor of Pediatrics and Senior Associate Dean for Clinical and Translational Research at RWJMS, has joined CHI as a new faculty member and resident scientist.  Dr. Radovick previously served as the Lawson Wilkins Professor, Director of the Division of Endochrinology and Vice Chair for Research and Development of Pediatrics at the Johns Hopkins University School of Medicine. 

 

Horacio J. Novaira, PhD, Assistant Professor of Pediatrics, also from Johns Hopkins University School of Medicine, has joined CHI as a new resident faculty member and scientist.

 

Dr. Radovick's new labatory is located at CHI on the 3rd Floor.